Uscom definitely has clinical utility. Tons of articles on scholar backing the technology. It's just that it takes a lot of effort to change the gold standard method that's been in use for decades. Covid-19 probably sped up the adoption of Uscom-1a devices and should accelerate the sales with more studies conducted on its clinical utility.
- Forums
- ASX - By Stock
- UCM
- COVID19 - USCOM1A sales
COVID19 - USCOM1A sales, page-46
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UCM (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.992M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7466 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7466 | 0.012 |
1 | 90000 | 0.011 |
2 | 400099 | 0.010 |
1 | 100000 | 0.009 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 60000 | 1 |
0.020 | 52000 | 2 |
0.022 | 36903 | 1 |
0.030 | 10083 | 1 |
0.050 | 42345 | 1 |
Last trade - 16.12pm 28/08/2024 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online